A detailed history of Wexford Capital LP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Wexford Capital LP holds 48,802 shares of MRK stock, worth $6.32 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares
48,802
Previous 38,240 27.62%
Holding current value
$6.32 Million
Previous $4.17 Million 54.49%
% of portfolio
1.35%
Previous 0.92%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $1.2 Million - $1.39 Million
10,562 Added 27.62%
48,802 $6.44 Million
Q4 2023

Feb 15, 2024

BUY
$100.18 - $109.02 $3.65 Million - $3.98 Million
36,474 Added 2065.35%
38,240 $4.17 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $3.7 Million - $4.04 Million
-34,101 Reduced 95.08%
1,766 $203,000
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $3.69 Million - $4.12 Million
35,867 New
35,867 $3.82 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $328B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Wexford Capital LP Portfolio

Follow Wexford Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wexford Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Wexford Capital LP with notifications on news.